MYC and Miyoshi myopathy: In this study, we utilized a multi-omics approach (Supplementary Fig. 1) to illustrate that the clinically relevant, immunocompetent Vk*MYC mouse model can faithfully replicate some of the key genomic events that are spontaneously acquired and selected during the progression of MM in humans7.